FASLG and neoplasm: On the other hand, VEGF inhibits the adhesion of lymphocytes to endothelial cells through intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and Fas Ligand (FasL), thereby affecting the infiltration of T cells into the tumor tissue (85, 86).